CJC-1295 Injectable Syringes Recalled for Lack of Sterility Assurance
Thrive Health Solutions is recalling 60 syringes of CJC-1295 Injectable due to lack of assurance of sterility. Non-sterile injectables pose a risk of infection to patients.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard—lack of assurance of sterility in injectable products—represents a risk of serious infection if administered, meeting the criterion for score 3 (High) as a risk-of-harm product without reported injury.
Plain-English summary
Thrive Health and Wellness, LLC, dba Thrive Health Solutions is recalling CJC-1295 Injectable (6 mg and 15 mg per syringe) supplied in pre-filled syringes. The recall affects 60 syringes distributed nationwide in the United States.
The recall was initiated due to lack of assurance of sterility in the manufacturing process. Non-sterile injectable products pose a risk of serious infection if administered.
Patients who have received this product should consult their healthcare provider immediately. Lot numbers H261968 (Exp 12/23/2025) and H261358 (Exp 5/13/2025) are affected. Healthcare providers and patients should discontinue use of affected syringes and contact Thrive Health Solutions or their healthcare provider for guidance.
No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- CJC-1295 Injectable, 6mg/15mg, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
- Manufacturer
- Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
- Hazard
- lack-of-sterility
- contamination-risk
- injectable-safety
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: H261968
- Exp 12/23/2025
- H261358
- Exp 5/13/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27